Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Drug Allergy
•
Urticaria/Angioedema
Do you believe that pretreatment with montelukast or other LTRAs can reduce the risk of urticaria or angioedema with NSAIDS?
Related Questions
How do you approach performing a food challenge in a patient with CSU who is dependent on their H1 blockers?
Are you managing chronic urticaria/angioedema any differently if the patient is only/predominantly presenting with urticaria or angioedema?
Has anyone had experience/success treating depressions/anxiety with an SSRI and having resolution of urticaria/angioedema despite 4X H1 dosing and +/- Xoliar?
Would you still consider omalizumab for CSU with angioedema in a patient with Factor V Leiden deficiency?
Are you using any AI models to de-label penicillin allergy?
For a positive anti-TPO and normal TSH in the workup of CSU, are you referring to endocrinology?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
What is your preferred prophylactic agent in idiopathic angioedema?
Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
